3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
5
Gastrointestinal
2
Breast
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Ovarian Neoplasms
2
Uterine Neoplasms
1
Neoplasms
1
Myofibroma
1
Lung Neoplasms
1
Liver Neoplasms
1
Endometrial Neoplasms
1
Brain Neoplasms
1
Agnosia
1
Interventions
Paclitaxel
28
Carboplatin
28
pembrolizumab
25
Bevacizumab
14
liposomal doxorubicin
12
Cisplatin
11
Gemcitabine
10
Radiotherapy
8
Drug Therapy
8
Cyclophosphamide
8
Blood Specimen Collection
8
Topotecan
7
Nivolumab
7
olaparib
6
Doxorubicin
6
niraparib
5
Therapeutics
5
Dexamethasone
5
pertuzumab
4
pazopanib
4
lenvatinib
4
fludarabine
4
cemiplimab
4
atezolizumab
4
Trastuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Fulvestrant
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Propofol
×
Gynecologic
×
Clear all
NCT00531349
2016-05-09
ECA/R
The Cleveland Clinic
Phase 3
Withdrawn